US FDA Grants Fast Track Designation for Paradigm’s Phase 3 Osteoarthritis ProgramFDA Fast Track Designation for Pentosan Polysulfate Sodium (Zilosul™/PPS) offers pathways to expedite development of Paradigm’s osteoarthritis clinicalFDA Fast Track acknowledges osteoarthritis as a serious disease wi.